Sinopep released its half-year performance, with a net profit attributable to the parent company of 310 million yuan, an increase of 36.49%
ST Sinopep released its 2025 semi-annual report, with operating revenue of 1.048 billion yuan, a year-on-year increase of 26.07%; net profit attributable to shareholders was 310 million yuan, a year-on-year increase of 36.49%. The net profit after deducting non-recurring gains and losses was 306 million yuan, a year-on-year increase of 33.49%. Basic earnings per share were 0.99 yuan, mainly benefiting from the growth in sales revenue of peptide raw materials
According to the Zhitong Finance APP, ST Sinopep (688076.SH) released its semi-annual report for 2025, showing an operating income of 1.048 billion yuan, a year-on-year increase of 26.07%. The net profit attributable to shareholders of the listed company was 310 million yuan, a year-on-year increase of 36.49%. The net profit attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 306 million yuan, a year-on-year increase of 33.49%. The basic earnings per share were 0.99 yuan.
During the reporting period, the operating income increased by 26.07% compared to the same period last year, mainly due to the year-on-year growth in sales revenue of the company's peptide raw materials, resulting in good growth in operating income
